Contrariwise, it has been recently shown that breast and ovarian cancer risks differ depending on the position and the type of BRCA1 and BRCA2 mutations (Rebbeck et al., 2015) meaning challenges regarding their structure and function. This evidence concerns the gene BRCA1 and ovarian carcinoma.